10/06/2026
Here we go again: abortion advocacy dressed up in a lab coat.
A “new peer-reviewed study” is being promoted as evidence that the FDA lacked justification for removing mifepristone’s in-person dispensing requirement.
Here’s the context missing from the headline:
The authors are affiliated with the anti-abortion Charlotte Lozier Institute, and Issues in Law & Medicine has published scholarship advancing anti-abortion positions.
More importantly, the paper does not uncover a new safety problem with mifepristone. It does not demonstrate that telehealth prescribing is unsafe. It argues that the FDA should have kept a restriction in place.
That’s a critique of FDA policy—not a newly discovered medical danger.
“Peer-reviewed” doesn’t erase ideology, conflicts, or context.
If remote dispensing is harming women, show the data.
Otherwise, stop presenting another argument for restricting abortion access as a new scientific discovery.
